US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Acyclovir Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

What was recalled

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Recalling firm
Apace KY LLC
NDC code
50268-061-11
Origin
KY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0544-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Acyclovir recalls

See all
Class II · Moderate risk Ongoing

acyclovir sodium

Reason Lack of Assurance of Sterility

Fresenius Kabi Compounding, LLC NDC 71506-035-56 D-0333-2026
Class III · Low risk Completed

Valacyclovir Tablets USP

Reason Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.

Viatris Inc NDC 0378-4275-77 D-0481-2024
Class II · Moderate risk Ongoing

Acyclovir Oral Suspension

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0782-2023
Class II · Moderate risk Ongoing

Acyclovir Sodium Injection 1

Reason Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

Eugia US LLC NDC 55150-155-20 D-0095-2023
Class II · Moderate risk Completed

Acyclovir Sodium Injection

Reason Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023